Q3 2025 Artivion Inc Earnings Call Transcript

Nov 6, 2025 / 09:30 PM GMT

Release Date Price: $47.5 (+2.13%)

Transcript 10-Q8-K

Key Points

Positve

Artivion Inc (AORT) reported a strong quarter with a 16% increase in constant currency revenue and a 39% growth in adjusted EBITDA year over year.
Stent graft revenues grew by 31% on a constant currency basis, driven by the successful launch and adoption of AMDS in the US.
Onyx heart valve business showed exceptional growth with a 23% increase in revenue, supported by its unique clinical profile and market share gains.
The company has made strategic investments in expanding its operational footprint, including purchasing facilities in Austin, Texas, to support future growth.
Artivion Inc (AORT) has a robust pipeline with promising products like AMDS and Nexus, which are expected to unlock significant market opportunities in the coming years.

Negative

The company faced a cybersecurity incident in 2024, which continues to have financial implications, including ongoing costs and insurance reimbursement delays.
Despite strong growth, the tissue processing revenue only increased by 5%, and the company expects full-year revenue to be flat compared to 2024.
Bioglue revenues grew by just 1%, with expectations of mid-single-digit growth being impacted by stock and distributor business variability.
Artivion Inc (AORT) anticipates being slightly cash flow negative for the full year 2025 due to a $12 million opportunistic purchase, although it expects to be cash flow positive in 2026.
The company faces challenges in the Chinese market, with expectations for Bioglue in China being conservative due to geopolitical and market complexities.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AORT.N - Artivion Inc
Q3 2025 Artivion Inc Earnings Call
Nov 06, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Artivan 3rd quarter 2025 earnings call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Lane Morgan from the Gilmartin Group.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, operator. Good afternoon and thank you for joining the call today.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.